Emergent BioSolutions
EBS
#6746
Rank
A$0.96 B
Marketcap
A$18.18
Share price
3.88%
Change (1 day)
24.00%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$1.32 Billion

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are A$1.32 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$1.45 B-15.38%
2023-12-31A$1.72 B-34.08%
2022-12-31A$2.61 B40.76%
2021-12-31A$1.85 B-0.58%
2020-12-31A$1.86 B5.56%
2019-12-31A$1.76 B2.3%
2018-12-31A$1.72 B755.19%
2017-12-31A$0.20 B-61.01%
2016-12-31A$0.51 B0.11%
2015-12-31A$0.51 B10%
2014-12-31A$0.47 B205.64%
2013-12-31A$0.15 B31.16%
2012-12-31A$0.11 B-7.42%
2011-12-31A$0.12 B1.71%
2010-12-31A$0.12 B11.13%
2009-12-31A$0.11 B-13.36%
2008-12-31A$0.12 B10.71%
2007-12-31A$0.11 B-7.52%
2006-12-31A$0.12 B128.15%
2005-12-31A$55.48 M-6.88%
2004-12-31A$59.58 M
2002-12-31A$33.07 M-70.75%
2001-12-31A$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merck
MRK
A$117.11 B 8,737.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$42.42 M-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$92.44 B 6,876.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
A$75.53 M-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.43 B 13,062.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.18 B 3,611.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
A$5.57 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA